Results 141 to 150 of about 34,277 (277)

Mapping Alzheimer's disease heterogeneity with molecular imaging biomarkers

European Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
This review outlines positron emission tomography (PET) biomarkers used in Alzheimer's disease (AD) research and clinical settings, targeting both specific (amyloid, tau) and non‐specific (neurodegeneration, synaptic density, neuroinflammation) processes.
Elif Harput, Cecilia Boccalini, Gregory Mathoux, John O. Prior, Nathalie Testart, Mario Jreige, Valentina Garibotto   +6 more
wiley   +1 more source

An Atypical Case of Progressive Supranuclear Palsy [PDF]

, 1984
Andrew Gomori, Anders A. F. Sima
openalex   +1 more source

MAPT‐Associated Familial Progressive Supranuclear Palsy with Typical Corticobasal Degeneration Neuropathology: A Clinicopathological Report [PDF]

, 2023
Patrick W. Cullinane, Riona Fumi, Marte Theilmann Jensen, Edwin Jabbari, Thomas T. Warner, Tamás Révész, Huw R. Morris, Jonathan D. Rohrer, Zane Jaunmuktane   +8 more
openalex   +1 more source

The Utility of Olfactory Testing to Discriminate Parkinson's Disease From Diagnostic Mimics: A Systematic Review and Meta‐Analysis

European Journal of Neurology, Volume 33, Issue 1, January 2026.
ABSTRACT Background Hyposmia is present in most patients with Parkinson's disease (PD), whereas olfaction is usually preserved in its diagnostic mimics. To address the limited evidence from smaller studies, we conducted a meta‐analysis on the diagnostic accuracy of olfactory testing in differentiating PD from clinical look‐alikes.
Christoph Theyer, Johannes Kirchmair, Frank Jagusch, Simon Leiter, Atbin Djamshidian, Beatrice Heim, Corinne Horlings, Alessandra Fanciulli, Werner Poewe, Klaus Seppi, Philipp Mahlknecht, Florian Krismer   +11 more
wiley   +1 more source

Similarities between familial and sporadic autopsy-proven progressive supranuclear palsy [PDF]

, 2013
Shinsuke Fujioka, Avi A. Algom, Melissa E. Murray, Audrey Strongosky, Alexandra I. Soto‐Ortolaza, Rosa Rademakers, Owen A. Ross, Zbigniew K. Wszołek, Dennis W. Dickson   +8 more
openalex   +1 more source

Extracellular Vesicle‐Derived microRNAs as Fluid Biomarkers in Neurodegenerative Diseases: A Systematic Review

Journal of Neurochemistry, Volume 170, Issue 1, January 2026.
Given the absence of curative treatments for neurodegenerative diseases, early detection and therapeutic intervention are critical to slowing disease progression. The last decade has seen accumulating evidence for microRNA dysregulation in circulating extracellular vesicles (EVs); however, assessing reproducibility between studies remains challenging ...
Aliyah Zaman, Sienna S. Drake, Alyson E. Fournier   +2 more
wiley   +1 more source

“Rapidly” Progressive Supranuclear Palsy [PDF]

Movement Disorders Clinical Practice, 2014
Melissa J, Armstrong, Rudy J, Castellani, Stephen G, Reich   +2 more
openaire   +2 more sources

Identification of Genetic Variants in Progressive Supranuclear Palsy in Southeast Asia [PDF]

Adeline Su Lyn Ng, Ai Huey Tan, Yi Jayne Tan, Jia Lun Lim, Michelle Mulan Lian, Alfand Marl F. Dy Closas, Azlina Ahmad‐Annuar, Shanthi Viswanathan, Yuen Kang Chia, Jia Nee Foo, Weng Khong Lim, Eng‐King Tan, Shen‐Yang Lim   +12 more
openalex   +1 more source

Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors [PDF]

, 2021
Michelle Oyeka, Terngu Ibilah, Jacob S. Israel, Jose Gavito-Higuera, Ricardo Salazar   +4 more
openalex   +1 more source

Loss of Striatal [⁷⁶Br]Bromospiperone Binding Sites Demonstrated by Positron Tomography in Progressive Supranuclear Palsy [PDF]

, 1986
Jean‐Claude Baron, B. Mazièré, Christian Loc’h, H Cambon, P. Sgouropoulos, Muriel Bonnet, Yves Agid   +6 more
openalex   +1 more source